Accelerating Hope: Clinical Trials for Hard-to-Treat Cancers Award supports researchers conducting clinical trials for hard-to-treat childhood cancers to advance safer, less toxic therapies.
Acceleration Initiative Award supports researchers pursuing translational and preclinical pediatric cancer treatment research to overcome development barriers and reach clinical trials within three years.
A Collaborative Pediatric Cancer Research Awards Program supports fellows, investigators, and consortia studying childhood cancers to advance discoveries, safer treatments, and patients’ quality of life.
Accelerator Awards support investigators pursuing ambitious four-year neuroendocrine cancer research to advance early detection, develop new therapies, and match treatments to individual tumor biology.
Clinical Trial Grant - Cannonball Kids' cancer Foundation supports researchers developing innovative pediatric cancer trials to expand treatment options, improve quality of life, and relieve symptoms.
Childhood Cancer Research Grants support investigators, including beginning scientists and physician-scientists, in targeted research to improve childhood cancer survival while protecting long-term health.